Axoval neuropathy as initial manifestation of primary amyloidosis: report of a case submitted to bone marrow transplantation

Arquivos de neuro-psiquiatria
Orlando G Povoas BarsottiniNelson Hamerschlak

Abstract

Amyloidosis is a syndrome characterized by deposition of a highly insoluble protein material in the extracellular space that may affect several organs. It may be generalized and idiopathic (primary amyloidosis). We describe the case of a 48 years-old woman with axonal neuropathy associated with proteinuria, whose final investigation resulted in diagnosis of primary amyloidosis (AL). She was submitted to autologous bone marrow transplantation. We discuss some aspects related to diagnosis of neuropathy and current treatment of AL.

References

Jul 1, 1979·Annals of Neurology·J J KellyP J Dyck
Sep 26, 1997·The New England Journal of Medicine·R H FalkM Skinner
Jul 17, 2001·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·A DispenzieriM A Gertz
Feb 22, 2002·The New England Journal of Medicine·Robert A KyleL Joseph Melton
May 31, 2002·Blood·Raymond L Comenzo, Morie A Gertz
Aug 9, 2003·Drugs·Leonard T Heffner, Sagar Lonial

❮ Previous
Next ❯

Citations

Apr 20, 2006·Arquivos de neuro-psiquiatria·Marcos C LangeCarmen M S Bonfim
Jun 1, 2006·Journal of Clinical Neuromuscular Disease·Jebin M Chacko, Warren D Spinner

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.